Travere Therapeutics Inc (NASDAQ: TVTX) kicked off on Tuesday, up 4.82% from the previous trading day, before settling in for the closing price of $20.13. Over the past 52 weeks, TVTX has traded in a range of $5.12-$21.56.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2.15% over the past five years. While this was happening, its average annual earnings per share was recorded -143.76%. With a float of $85.89 million, this company’s outstanding shares have now reached $87.03 million.
Let’s look at the performance matrix of the company that is accounted for 380 employees. In terms of profitability, gross margin is 84.29%, operating margin of -169.03%, and the pretax margin is -171.4%.
Travere Therapeutics Inc (TVTX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Travere Therapeutics Inc is 1.31%, while institutional ownership is 97.71%. The most recent insider transaction that took place on Jan 22 ’25, was worth 47,424. In this transaction SENIOR VICE PRESIDENT, R&D of this company sold 2,437 shares at a rate of $19.46, taking the stock ownership to the 83,170 shares. Before that another transaction happened on Jan 22 ’25, when Company’s CHIEF EXECUTIVE OFFICER sold 10,736 for $19.46, making the entire transaction worth $208,923. This insider now owns 351,239 shares in total.
Travere Therapeutics Inc (TVTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -143.76% per share during the next fiscal year.
Travere Therapeutics Inc (NASDAQ: TVTX) Trading Performance Indicators
Take a look at Travere Therapeutics Inc’s (TVTX) current performance indicators. Last quarter, stock had a quick ratio of 1.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.56, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.13 in one year’s time.
Technical Analysis of Travere Therapeutics Inc (TVTX)
Travere Therapeutics Inc (NASDAQ: TVTX) saw its 5-day average volume 1.46 million, a positive change from its year-to-date volume of 1.3 million. As of the previous 9 days, the stock’s Stochastic %D was 77.62%. Additionally, its Average True Range was 1.07.
During the past 100 days, Travere Therapeutics Inc’s (TVTX) raw stochastic average was set at 96.24%, which indicates a significant increase from 90.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.85% in the past 14 days, which was higher than the 64.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.43, while its 200-day Moving Average is $12.46. Nevertheless, the first resistance level for the watch stands at $21.68 in the near term. At $22.27, the stock is likely to face the second major resistance level. The third major resistance level sits at $23.16. If the price goes on to break the first support level at $20.20, it is likely to go to the next support level at $19.31. The third support level lies at $18.72 if the price breaches the second support level.
Travere Therapeutics Inc (NASDAQ: TVTX) Key Stats
The company with the Market Capitalisation of 1.84 billion has total of 78,050K Shares Outstanding. Its annual sales at the moment are 145,240 K in contrast with the sum of -111,400 K annual income. Company’s last quarter sales were recorded 62,900 K and last quarter income was -54,810 K.